Skip to content

VIATRAC 1008193-40Recalls & reported problems

Abbott Vascular Inc. · VIATRAC 14 Plus Peripheral Dilatation Catheter 5.0 mm x 40 mm x 135 cm · Class 2

All models of VIATRAC (22)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648057007), received between Oct 19, 2023 and Oct 19, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Difficult to Advance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Advance1
  • Difficult to Remove1
  • Improper or Incorrect Procedure or Method1
  • Material Rupture1
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 19, 2023Difficult to Remove; Material Rupture; Material Separation; Improper or Incorrect Procedure or Method; Difficult to Advance; Difficult to Remove; Material Rupture; Material Separation; Improper or Incorrect Procedure or Method; Difficult to Advance

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A STENOSED LESION IN THE LEFT COMMON CAROTID ARTERY WITH HEAVY CALCIFICATION AT THE BIFURCATION. PUNCTURE WAS AT THE RIGHT FEMORAL ARTERY. PRE-DILATATION WAS PERFORMED USING A 4.0X20MM VIATRAC BALLOON. AN EMBOSHIELD NAV 6 FILTER WAS POSITIONED AND A 7.0-9.0X40MM XACT CAROTID STENT SYSTEM FAILED TO CROSS DUE TO THE ANATOMY. ANOTHER 5.0X40MM VIATRAC BALLOON DILATATION CATHETER (BDC) WAS ADVANCED WITH RESISTANCE TO THE LESION AND THE BALLOON RUPTURED DURING THE FIRST INFLATION AT 10 ATMOSPHERES (ATMS). HOWEVER, THE BALLOON "STRIPPED" ON THE CALCIFICATION AND SEPARATED WITH THE DISTAL PART REMAINING IN THE ANATOMY DISTAL TO THE TIP OF THE INTRODUCER DURING REMOVAL. AN ATTEMPT TO REMOVE ALL THE DEVICES WAS MADE INCLUDING THE GUIDE CATHETER, EMBOSHIELD NAV 6 FILTER AND THE SEPARATED PORTION OF THE BALLOON USING THE GUIDE WIRE IN PLACE BUT FAILED AS THE DEVICES REMAINED BLOCKED DUE TO THE ISSUE WITH THE BALLOON. THE PROCEDURE WAS IMMEDIATELY CONVERTED TO AN OPEN SURGERY FOR A CAROTID-CAROTID BYPASS. NOTHING REMAINS IN THE ANATOMY. THERE WAS NO ADVERSE PATIENT SEQUELAE AND THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. N

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17966046 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page